Z. Yu

Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective study.

G. Gerken, V. Cicinnati, S. Beckebaum, 2004, Transplantation proceedings.

Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients

H. Chen, Z. Yu, W. Cai, 2008, Xenobiotica; the fate of foreign compounds in biological systems.

134 Impact of combined mycophenolate mofetil and low dose calcineurin inhibitor therapy on T cell function

G. Gerken, V. Cicinnati, S. Beckebaum, 2006 .

Influence of the MDR1 haplotype and CYP3A5 genotypes on cyclosporine blood level in Chinese renal transplant recipients

J. Li, Z. Yu, J. Fang, 2009, Xenobiotica; the fate of foreign compounds in biological systems.

Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients – assessment of renal and allograft function, cardiovascular risk factors and immune monitoring

G. Gerken, V. Cicinnati, S. Beckebaum, 2007, Alimentary pharmacology & therapeutics.

Clinical trial of arotinolol in the treatment of hypertension: dippers vs. non-dippers.

Y. Zhou, Z. Yu, Y. Zhang, 2001, Hypertension research : official journal of the Japanese Society of Hypertension.